Literature DB >> 23536279

High frequency of temperature-sensitive mutants of p53 in glioblastoma.

Jana Smardova1, Kvetoslava Liskova, Barbora Ravcukova, Lenka Kubiczkova, Sabina Sevcikova, Jaroslav Michalek, Miluse Svitakova, Vaclav Vybihal, Leos Kren, Jan Smarda.   

Abstract

Glioblastoma is the most common and the most aggressive type of brain cancer. Aberrations of the RTK/RAS/PI3K-, p53-, and RB cell signaling pathways were recognized as a core requirement for pathogenesis of glioblastoma. The p53 tumor suppressor functions as a transcription factor transactivating expression of its target genes in response to various stress stimuli. We determined the p53 status in 36 samples of glioblastoma by functional analyses FASAY and split assay. Seventeen p53 mutations were detected and further analyzed by cDNA and gDNA sequencing in 17 patients (47.2 %). Fifteen (88.2 %) of the mutations were missense mutations causing amino acid substitutions, seven of them exhibited temperature-sensitivity. Two mutations were determined as short deletions, one of them causing formation of premature termination codon in position 247. Fluorescent in situ hybridization revealed the loss of the p53-specific 17p13.3 locus in four of 33 analyzed samples (12 %). In 12 out of 30 samples (40 %), the p53 protein accumulation was shown by immunoblotting. There was high (80 %) concordance between the presence of the clonal p53 mutation and the p53 protein accumulation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23536279     DOI: 10.1007/s12253-012-9596-7

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  47 in total

1.  TP53 gene mutations, nuclear p53 accumulation, expression of Waf/p21, Bcl-2, and CD95 (APO-1/Fas) proteins are not prognostic factors in de novo glioblastoma multiforme.

Authors:  J A Kraus; M Wenghoefer; N Glesmann; S Mohr; M Beck; M C Schmidt; R Schröder; U Berweiler; W Roggendorf; S Diete; K Dietzmann; K Heuser; B Müller; R Fimmers; A von Deimling; U Schlegel
Journal:  J Neurooncol       Date:  2001-05       Impact factor: 4.130

2.  Rare somatic p53 mutation identified in breast cancer: a case report.

Authors:  J Smardová; A Nemajerová; M Trbusek; V Vagunda; J Kovarík
Journal:  Tumour Biol       Date:  2001 Mar-Apr

3.  Impact of genotype and morphology on the prognosis of glioblastoma.

Authors:  Matthias C Schmidt; Sven Antweiler; Nina Urban; Wolf Mueller; A Kuklik; Birgit Meyer-Puttlitz; Otmar D Wiestler; David N Louis; Rolf Fimmers; Andreas von Deimling
Journal:  J Neuropathol Exp Neurol       Date:  2002-04       Impact factor: 3.685

Review 4.  The WHO classification of tumors of the nervous system.

Authors:  Paul Kleihues; David N Louis; Bernd W Scheithauer; Lucy B Rorke; Guido Reifenberger; Peter C Burger; Webster K Cavenee
Journal:  J Neuropathol Exp Neurol       Date:  2002-03       Impact factor: 3.685

5.  Reappraisal of p53 mutations in human malignant astrocytic neoplasms by p53 functional assay: comparison with conventional structural analyses.

Authors:  M Tada; R D Iggo; F Waridel; M Nozaki; R Matsumoto; Y Sawamura; Y Shinohe; J Ikeda; H Abe
Journal:  Mol Carcinog       Date:  1997-03       Impact factor: 4.784

6.  Human tumor-derived p53 proteins exhibit binding site selectivity and temperature sensitivity for transactivation in a yeast-based assay.

Authors:  C J Di Como; C Prives
Journal:  Oncogene       Date:  1998-05-14       Impact factor: 9.867

7.  Isolation of temperature-sensitive p53 mutations from a comprehensive missense mutation library.

Authors:  Kazuko Shiraishi; Shunsuke Kato; Shuang-Yin Han; Wen Liu; Kazunori Otsuka; Masato Sakayori; Takanori Ishida; Motohiro Takeda; Ryunosuke Kanamaru; Noriaki Ohuchi; Chikashi Ishioka
Journal:  J Biol Chem       Date:  2003-10-13       Impact factor: 5.157

8.  Analysis of transactivation capability and conformation of p53 temperature-dependent mutants and their reactivation by amifostine in yeast.

Authors:  D Grochova; J Vankova; J Damborsky; B Ravcukova; J Smarda; B Vojtesek; J Smardova
Journal:  Oncogene       Date:  2007-09-03       Impact factor: 9.867

9.  A simple p53 functional assay for screening cell lines, blood, and tumors.

Authors:  J M Flaman; T Frebourg; V Moreau; F Charbonnier; C Martin; P Chappuis; A P Sappino; I M Limacher; L Bron; J Benhattar
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-25       Impact factor: 11.205

10.  High frequency of temperature-sensitive mutations of p53 tumor suppressor in acute myeloid leukemia revealed by functional assay in yeast.

Authors:  Sarka Pavlova; Jiri Mayer; Hana Koukalova; Jana Smardova
Journal:  Int J Oncol       Date:  2003-07       Impact factor: 5.650

View more
  5 in total

Review 1.  Familial/inherited cancer syndrome: a focus on the highly consanguineous Arab population.

Authors:  Fawz S AlHarthi; Alya Qari; Alaa Edress; Malak Abedalthagafi
Journal:  NPJ Genom Med       Date:  2020-02-03       Impact factor: 8.617

2.  Self-aggregation and coaggregation of the p53 core fragment with its aggregation gatekeeper variant.

Authors:  Jiangtao Lei; Ruxi Qi; Guanghong Wei; Ruth Nussinov; Buyong Ma
Journal:  Phys Chem Chem Phys       Date:  2016-03-21       Impact factor: 3.676

3.  Intracellular CD24 disrupts the ARF-NPM interaction and enables mutational and viral oncogene-mediated p53 inactivation.

Authors:  Lizhong Wang; Runhua Liu; Peiying Ye; Chunshu Wong; Guo-Yun Chen; Penghui Zhou; Kaoru Sakabe; Xincheng Zheng; Wei Wu; Peng Zhang; Taijiao Jiang; Michael F Bassetti; Sandro Jube; Yi Sun; Yanping Zhang; Pan Zheng; Yang Liu
Journal:  Nat Commun       Date:  2015-01-20       Impact factor: 14.919

4.  OVCA1 expression and its correlation with the expression levels of cyclin D1 and p16 in cervical cancer and intraepithelial neoplasia.

Authors:  Rui Tong; Qing Yang; Chunyan Wang; Fangfang Bi; Bing Jiang
Journal:  Oncol Lett       Date:  2017-03-13       Impact factor: 2.967

Review 5.  Familial/inherited cancer syndrome: a focus on the highly consanguineous Arab population.

Authors:  Fawz S AlHarthi; Alya Qari; Alaa Edress; Malak Abedalthagafi
Journal:  NPJ Genom Med       Date:  2020-02-03       Impact factor: 8.617

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.